$ALTAltimmune, Inc.

Active trials

• phase3Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASHrecruitingn=1,800
• phase2RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)active not recruitingn=121
• phase2IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)completedn=212
• phase2HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)terminatedn=87
• phase2RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweightactive not recruitingn=100
• phase1NasoShield Study of Safety and Immunogenicitycompletedn=145
• phase1Pemvidutide (ALT-801) DDI Study in Healthy Volunteerscompletedn=40
• phase1NasoShield in Healthy Adults to Study Safety and Immunogenicitycompletedn=43